National Institute on Aging; Notice of Closed Meeting, 50630-50631 [2022-17631]
Download as PDF
<![CDATA[
50630
Federal Register / Vol. 87, No. 158 / Wednesday, August 17, 2022 / Notices
established in the last few decades;
however, FDA has become aware of an
increase in the number of adverse event
reports related to the misuse of these
products. These reports led FDA to
convene a meeting of the Ophthalmic
Devices Panel of the Medical Devices
Advisory Committee and the Risk
Communication Advisory Committee on
March 17, 2017, to discuss additional
measures to mitigate the potential risk
for misuse of these devices. The meeting
covered a range of important issues,
including appropriate labeling and
packaging of these products and the
importance of clearly communicating
these concerns to the consumer public,
which were incorporated into this draft
guidance. When finalized, this guidance
is intended to provide recommendations
concerning the content and format of
labeling for HPCPs. FDA believes that
the labeling recommendations in this
guidance may help manufacturers
develop labeling with information about
specific risks and directions for use of
the HPCPs in conjunction with a user’s
prescribed contact lenses.
This draft guidance is being issued
consistent with FDA’s good guidance
II. Electronic Access
Persons interested in obtaining a copy
of the draft guidance may do so by
downloading an electronic copy from
the internet. A search capability for all
Center for Devices and Radiological
Health guidance documents is available
at https://www.fda.gov/medical-devices/
device-advice-comprehensiveregulatory-assistance/guidancedocuments-medical-devices-andradiation-emitting-products. This
guidance document is also available at
https://www.regulations.gov or https://
www.fda.gov/regulatory-information/
search-fda-guidance-documents.
Persons unable to download an
electronic copy of ‘‘Hydrogen PeroxideBased Contact Lens Care Products:
Consumer Labeling Recommendations—
Premarket Notification (510(k))
Submissions’’ may send an email
request to CDRH-Guidance@fda.hhs.gov
to receive an electronic copy of the
document. Please use the document
number 18041 and complete title to
identify the guidance you are
requesting.
III. Paperwork Reduction Act of 1995
While this guidance contains no new
collection of information, it does refer to
previously approved FDA collections of
information. Therefore, clearance by the
Office of Management and Budget
(OMB) under the Paperwork Reduction
Act of 1995 (PRA) (44 U.S.C. 3501–
3521) is not required for this guidance.
The previously approved collections of
information are subject to review by
OMB under the PRA. The collections of
information in the following FDA
regulations, guidance, and forms have
been approved by OMB as listed in the
following table:
OMB control
No.
21 CFR part
Topic
807, subpart E ............................................................................
800, 801, and 809 ......................................................................
Premarket notification .................................................................
Medical Device Labeling Regulations ........................................
Dated: August 11, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
FOR FURTHER INFORMATION CONTACT:
[FR Doc. 2022–17642 Filed 8–16–22; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Senior Executive Service Performance
Review Board
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
AGENCY:
ACTION:
Notice.
HRSA, an operating division
of HHS, is publishing a list of
individuals who may be named to serve
on the Senior Executive Service
Performance Review Board that oversees
the evaluation of performance
appraisals for Senior Executive Service
members for the Fiscal Years 2022 and
2023.
SUMMARY:
JSPEARS on DSK121TN23PROD with NOTICES
practices regulation (21 CFR 10.115).
The draft guidance, when finalized, will
represent the current thinking of FDA
on ‘‘Hydrogen Peroxide-Based Contact
Lens Care Products: Consumer Labeling
Recommendations—Premarket
Notification (510(k)) Submissions.’’ It
does not establish any rights for any
person and is not binding on FDA or the
public. You can use an alternative
approach if it satisfies the requirements
of the applicable statutes and
regulations.
VerDate Sep<11>2014
17:22 Aug 16, 2022
Jkt 256001
Georgia Lyons, HRSA Executive
Resources, Office of Human Resources,
5600 Fishers Lane, Rm 12N06C,
Rockville, Maryland 20857, or (301)
443–4618.
SUPPLEMENTARY INFORMATION: Title 5,
U.S.C. Section 4314(c)(4) of the Civil
Service Reform Act of 1978, Public Law
95–454, requires that the appointment
of Performance Review Board Members
be published in the Federal Register.
The following individuals may be
named to serve on the Senior Executive
Service Performance Review Board:
Onyekachukwu Anaedozie
Anthony Archeval
Cynthia Baugh
Tonya Bowers
Adriane Burton
Tina Cheatham
Laura Cheever
Christopher Coppenbarger
Natasha Coulouris
Cheryl Dammons
Elizabeth DeVoss
Tanette Downs
Diana Espinosa
Catherine Ganey
Alexandra Garcia
Jordan Grossman
Heather Hauck
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
0910–0120
0910–0485
Alexandra Huttinger
Carole Johnson
Laura Kavanagh
Martin Kramer
James Macrae
Maren McBride Kahn
Susan Monarez
Thomas Morris
Suma Nair
Luis Padilla
Nisha Patel
Krista Pedley
Wendy Ponton
Sheila Pradia Williams
Michael Warren
Carole Johnson,
Administrator.
[FR Doc. 2022–17657 Filed 8–16–22; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
E:\FR\FM\17AUN1.SGM
17AUN1
Federal Register / Vol. 87, No. 158 / Wednesday, August 17, 2022 / Notices
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Fasting
Mimicking Diets and Peptides in Normal
Aging and Alzheimer’s Disease.
Date: October 19, 2022.
Time: 11:30 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Aging, Gateway
Building, 7201 Wisconsin Avenue, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Bita Nakhai, Ph.D., Chief,
Basic and Translational Sciences Section
(BTSS), Scientific Review Branch, National
Institute on Aging, Gateway Bldg., 2C212,
7201 Wisconsin Avenue, Bethesda, MD
20814, 301–402–7701, nakhaib@nia.nih.gov.
Information is also available on the
Institute’s/Center’s home page:
www.nia.nih.gov/, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: August 11, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–17631 Filed 8–16–22; 8:45 am]
National Institute of General Medical
Sciences; Notice of Closed Meeting
JSPEARS on DSK121TN23PROD with NOTICES
[FR Doc. 2022–17701 Filed 8–16–22; 8:45 am]
BILLING CODE 4140–01–P
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Meeting
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
Jkt 256001
Dated: August 12, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
17:22 Aug 16, 2022
Name of Committee: NIGMS Initial Review
Group Training and Workforce Development
Study Section—C Training and Workforce
Development Study Section C (TWD–C)—
Review of MARC and U–RISE Applications.
Date: October 13–14, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of General Medical
Science, Natcher Bldg. 45, 45 Center Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sonia Ivette OrtizMiranda, Ph.D., Scientific Review Officer,
National Institute of General Medical
Sciences, National Institutes of Health,
Bethesda, MD 20892, (301) 594–0534,
sonia.ortiz-miranda@nih.gov.
Information is also available on the
Institute’s/Center’s home page:
www.nigms.nih.gov/, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
VerDate Sep<11>2014
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Arthritis and
Musculoskeletal and Skin Diseases
Advisory Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The open
session will be videocast and can be
accessed from the NIH Videocasting
website (https://videocast.nih.gov/).
PO 00000
Frm 00033
Fmt 4703
Sfmt 9990
50631
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Arthritis and
Musculoskeletal and Skin Diseases Advisory
Council.
Date: September 14, 2022.
Open: 10:00 a.m. to 1:10 p.m.
Agenda: Discussion of Program Policies
and Issues.
Place: National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Blvd., Democracy I, Suite 800,
Bethesda MD 20892–4872, https://
videocast.nih.gov/ (Virtual Meeting).
Open: 2:00 p.m. to 2:30 p.m.
Agenda: Board of Scientific Counselors
Report.
Place: National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Blvd., Democracy I, Suite 800,
Bethesda MD 20892–4872, https://
videocast.nih.gov/ (Virtual Meeting).
Closed: 2:35 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Blvd., Democracy I, Suite 800,
Bethesda MD 20892–4872 (Virtual Meeting).
Contact Person: Kathy Salaita, SCD Chief,
Scientific Review Branch, National Institute
of Arthritis, Musculoskeletal and Skin
Diseases, National Institutes of Health, 6701
Democracy Blvd., Rm 818, Bethesda, MD
20892, 301–594–5033, kathy.salaita@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: August 12, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–17705 Filed 8–16–22; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\17AUN1.SGM
17AUN1
]]>Agencies
[Federal Register Volume 87, Number 158 (Wednesday, August 17, 2022)]
[Notices]
[Pages 50630-50631]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-17631]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
[[Page 50631]]
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Aging Special Emphasis
Panel; Fasting Mimicking Diets and Peptides in Normal Aging and
Alzheimer's Disease.
Date: October 19, 2022.
Time: 11:30 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on
Aging, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Bita Nakhai, Ph.D., Chief, Basic and
Translational Sciences Section (BTSS), Scientific Review Branch,
National Institute on Aging, Gateway Bldg., 2C212, 7201 Wisconsin
Avenue, Bethesda, MD 20814, 301-402-7701, [email protected].
Information is also available on the Institute's/Center's home
page: www.nia.nih.gov/, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging
Research, National Institutes of Health, HHS)
Dated: August 11, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-17631 Filed 8-16-22; 8:45 am]
BILLING CODE 4140-01-P
